{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-23-000080","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.647980+00:00","generated_at":"2026-06-12T18:24:18.981933+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Surgery Partners Q2 revenue $667.6M (+8.5% YoY), EBITDA beat; FY guidance raised","bullets":["Revenue $667.6M (+8.5% YoY); same-facility revenue +8.3% (~10% adj. for $8M cyber headwind).","Net income $18.9M vs ($18.4M) loss; Adjusted EBITDA $100.2M, +16.4% YoY; margin 15.0%.","FY 2023 Adjusted EBITDA guidance raised to >$435M; revenue reaffirmed >$2.75B; free cash flow >$140M.","Combined surgical case volume +5%; non-consolidated minority revenue +30%.","Deployed ~$60M capital in Q2; new partnership with Methodist Health System in Dallas, TX."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-23-000080","json":"https://secwatch.observer/filing/0001638833-23-000080.json","markdown":"https://secwatch.observer/filing/0001638833-23-000080.md","text":"https://secwatch.observer/filing/0001638833-23-000080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/sgry-20230801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T18:24:18.981933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"21879b114d6fb8b743c494552066b1bb4c79a203","claim":"Surgery Partners, Inc. reported for fiscal year 2023 results: revenue greater than $2.75 billion. Guidance raised.","evidence_excerpt":"Full year Adjusted EBITDA guidance raised to greater than $435 million, revenue reaffirmed at greater than $2.75 billion, inclusive of the cyber event, and free cash flow reaffirmed at greater than $140 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for fiscal year 2023"},{"label":"Revenue","value":"greater than $2.75 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"69e1cc2eccb8931cb9544077b16258777e678190","claim":"Surgery Partners, Inc. reported for the second quarter ended June 30, 2023 results: revenue Revenues were $667.6 million, net income Net income attributable to Surgery Partners was $18.9 million.","evidence_excerpt":"Surgery Partners, Inc. (NASDAQ:SGRY) (\"Surgery Partners\" or the \"Company\"), a leading provider of surgical services, today announced financial results for the second quarter ended June 30, 2023. • Revenues were $667.6 million representing 8.5% growth and are inclusive of an $8 million cyber event headwind • Same-facility revenues increased 8.3% on an unadjusted basis and approximately 10% adjusting for the cyber event • Non-consolidated minority interest revenue increased by over 30% • Net income attributable to Surgery Partners was $18.9 million • Adjusted EBITDA was $100.2 million, representing 16.4% growth • Adjusted EBITDA margin improved by over 100 basis points year-over-year to 15.0% • Combined, consolidated and unconsolidated surgical case volume grew 5%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000080/0001638833-23-000080-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the second quarter ended June 30, 2023"},{"label":"Revenue","value":"Revenues were $667.6 million"},{"label":"Net income","value":"Net income attributable to Surgery Partners was $18.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}